These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16620268)

  • 1. Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with Type 2 diabetes.
    Nazir FS; Alem M; Small M; Connell JM; Lees KR; Walters MR; Cleland SJ
    Diabet Med; 2006 Apr; 23(4):398-402. PubMed ID: 16620268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperemic response to hypercapnia.
    White RP; Deane C; Vallance P; Markus HS
    Stroke; 1998 Feb; 29(2):467-72. PubMed ID: 9472891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracarotid infusion of the nitric oxide synthase inhibitor, L-NMMA, modestly decreases cerebral blood flow in human subjects.
    Joshi S; Young WL; Duong DH; Ostapkovich ND; Aagaard BD; Hashimoto T; Pile-Spellman J
    Anesthesiology; 2000 Sep; 93(3):699-707. PubMed ID: 10969303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dose-response study of nitric oxide synthase inhibition in different vascular beds in man.
    Hjorth Lassen L; Klingenberg Iversen H; Olesen J
    Eur J Clin Pharmacol; 2003 Oct; 59(7):499-505. PubMed ID: 13680036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopurinol and nitric oxide activity in the cerebral circulation of those with diabetes: a randomized trial.
    Dawson J; Quinn T; Harrow C; Lees KR; Weir CJ; Cleland SJ; Walters MR
    Diabetes Care; 2009 Jan; 32(1):135-7. PubMed ID: 18945924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the nitric oxide synthase inhibitor L-NMMA on cerebrovascular and cardiovascular responses to hypoxia and hypercapnia in humans.
    Ide K; Worthley M; Anderson T; Poulin MJ
    J Physiol; 2007 Oct; 584(Pt 1):321-32. PubMed ID: 17673507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AT1 receptor blockade prevents the decrease in conduit artery flow-mediated dilatation during NOS inhibition in humans.
    Bellien J; Iacob M; Eltchaninoff H; Bourkaib R; Thuillez C; Joannides R
    Clin Sci (Lond); 2007 Jun; 112(7):393-401. PubMed ID: 17125466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic men.
    Tran D; Lowy A; Howes JB; Howes LG
    Diabetes Obes Metab; 2005 May; 7(3):273-81. PubMed ID: 15811145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ocular hemodynamic response to nitric oxide synthase inhibition is unaltered in patients with early type I diabetes.
    Dorner GT; Garhöfer G; Selenko N; Fasching P; Bayerle-Eder M; Schmetterer L; Wolzt M
    Graefes Arch Clin Exp Ophthalmol; 2003 Aug; 241(8):619-24. PubMed ID: 12836035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans.
    White RP; Vallance P; Markus HS
    Clin Sci (Lond); 2000 Dec; 99(6):555-60. PubMed ID: 11099400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal production of nitric oxide (NO) and non-NO vasodilators in the forearm microcirculation in Type 2 diabetes: associations with blood pressure and HDL cholesterol.
    Woodman RJ; Playford DA; Watts GF
    Diabetes Res Clin Pract; 2006 Jan; 71(1):59-67. PubMed ID: 16029909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide contributes to cerebrovascular shear-mediated dilatation but not steady-state cerebrovascular reactivity to carbon dioxide.
    Hoiland RL; Caldwell HG; Carr JMJR; Howe CA; Stacey BS; Dawkins T; Wakeham DJ; Tremblay JC; Tymko MM; Patrician A; Smith KJ; Sekhon MS; MacLeod DB; Green DJ; Bailey DM; Ainslie PN
    J Physiol; 2022 Mar; 600(6):1385-1403. PubMed ID: 34904229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylcholine acutely modifies nitric oxide synthase function in the human coronary circulation.
    Miner SE; Al-Hesayen A; Nield LE; Gori T; Parker JD
    Exp Physiol; 2010 Dec; 95(12):1167-76. PubMed ID: 20817701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased inflammatory activity parallels increased basal nitric oxide production and blunted response to nitric oxide in vivo in rheumatoid arthritis.
    Yki-Järvinen H; Bergholm R; Leirisalo-Repo M
    Ann Rheum Dis; 2003 Jul; 62(7):630-4. PubMed ID: 12810424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of nitric oxide synthase does not alter dynamic cerebral autoregulation in humans.
    Zhang R; Wilson TE; Witkowski S; Cui J; Crandall GG; Levine BD
    Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H863-9. PubMed ID: 15008160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide synthase inhibition with N(G)-monomethyl-l-arginine: Determining the window of effect in the human vasculature.
    Kithas AC; Broxterman RM; Trinity JD; Gifford JR; Kwon OS; Hydren JR; Nelson AD; Jessop JE; Bledsoe AD; Morgan DE; Richardson RS
    Nitric Oxide; 2020 Nov; 104-105():51-60. PubMed ID: 32979497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nitric oxide synthase inhibition and L-arginine on renal haemodynamics in young patients at high cardiovascular risk.
    Schlaich MP; Oehmer S; Schneider MP; Delles C; Schmidt BM; Schmieder RE
    Atherosclerosis; 2007 May; 192(1):155-60. PubMed ID: 16765359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nos inhibition on retinal arterial and capillary circulation in early arterial hypertension.
    Michelson G; Wärntges S; Harazny J; Oehmer S; Delles C; Schmieder RE
    Retina; 2006 Apr; 26(4):437-44. PubMed ID: 16603964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
    Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
    J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of endothelium-derived nitric oxide in sustained flow-dependent dilatation of human peripheral conduit arteries].
    Bellien J; Joannidès R; Iacob M; Eltchaninoff H; Thuillez Ch
    Arch Mal Coeur Vaiss; 2003; 96(7-8):738-41. PubMed ID: 12945214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.